Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Endocrinology, Diabetes & Metabolism|January 11, 2020
Dose distribution and up-titration patterns of metformin monotherapy in patients with type 2 diabetesKristy Iglay, Baanie Sawhney, Alex Z Fu, et al.Advances in Therapy|March 11, 2023
A Systematic Review of Epidemiology and Outcomes Associated with Local Surgical and Intersphincteric Ligation Procedures for Complex Cryptoglandular FistulasKristy Iglay, Dimitri Bennett, Michael D Kappelman, et al.Current Medical Research and Opinion|March 2, 2021
Comorbidities in type 2 diabetes patients with and without atherosclerotic cardiovascular disease: a retrospective database analysisKristy Iglay, Hakima Hannachi, Samuel S Engel, et al.Medicine|November 18, 2022
A systematic review of epidemiology and outcomes of Crohn's disease-related enterocutaneous fistulasKristy Iglay, Dimitri Bennett, Michael D Kappelman, et al.BMC Gastroenterology|January 29, 2022
A systematic review of the patient burden of Crohn's disease-related rectovaginal and anovaginal fistulasKristy Iglay, Dimitri Bennett, Michael D Kappelman, et al.BMJ Open Diabetes Research & Care|February 1, 2022
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UKTracey Weiss, Lingfeng Yang, Richard D Carr, et al.Current Medical Research and Opinion|February 25, 2015
Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapyAude Roborel de Climens, Kaan Tunceli, Benoit Arnould, et al.Patient Preference and Adherence|December 4, 2020
Real-World Adherence and Discontinuation of Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes Mellitus Patients in the United StatesTracey Weiss, Richard D Carr, Sampriti Pal, et al.Current Medical Research and Opinion|May 30, 2015
Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetesKristy Iglay, Shannon E Cartier, Virginia M Rosen, et al.Current Medical Research and Opinion|April 30, 2013
Time to initiation of oral antihyperglycemic and statin therapy in previously untreated patients with type 2 diabetes in the United StatesPeter Sun, Kaan Tunceli, Qiaoyi Zhang, et al.Pageof 5